Transgene expression enhancement in T-lymphoma cell lines

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• Achieving adequate transgene expression is critical in transfection protocols.
• Certain cell lines, particularly T-lymphoma cells, present challenges for high transgene expression.
• Understanding transgene expression kinetics is essential for optimizing gene delivery.

Purpose of the Study:

• To evaluate the effect of transcription activators, phorbol-12-myristate13-acetate (PMA) and Ionomicin (IO), on transgene expression kinetics.
• To determine if PMA and IO can enhance transgene expression in murine T-lymphoma cell lines.
• To assess the optimization potential of transcription activators for transgene expression in difficult-to-transfect cells.

Main Methods:

• Three murine T-lymphoma cell lines (LBC, EL4, BW5147) were utilized.
• Cells were transfected using electroporation with green fluorescent protein (GFP) as a reporter gene.
• Transgene expression was analyzed by flow cytometry in the presence and absence of PMA/IO.

Main Results:

• PMA/IO addition significantly increased Mean Fluorescence Intensity (MFI) in LBC and EL4 cells, indicating higher expression levels.
• GFP-positive cell percentages remained largely unchanged, suggesting PMA/IO primarily boosted expression from transfected cells, not the number of transfected cells.
• BW5147 cells showed limited GFP induction, with significant increases observed only in stably transfected cells.

Conclusions:

• Transcription activators PMA and IO can enhance cytomegalovirus (CMV) promoter activity in transfected T-lymphoma cells.
• The use of transcription activators offers a viable strategy to optimize transgene expression levels in challenging cell types.
• These findings provide a method for improving gene expression efficiency in T-lymphoma transfection.